RxDoctor Payments Data

Robert Lugliani

Pulmonary Disease · Long Beach, CANPI 1699712943

Payments from drug & device makers

$2,908in general payments, 2019–2025

Across 147 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$693
  • GSK$676
  • Mylan Specialty L.p.$407
  • Pfizer$288
  • Regeneron Healthcare Solutions, Inc.$209
  • Vanda Pharmaceuticals Inc.$140
  • plus $497 from 16 others

What the payments were for

  • Food & beverage$2,908100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,908 in reported general payments places this provider in the 55th percentile of 1,261 pulmonary disease providers in California.

See all pulmonary disease providers in California

Other pulmonary disease in Long Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →